Head to Head Comparison: Doximity (NYSE:DOCS) & Black Titan (NASDAQ:BTTC)

Doximity (NYSE:DOCS) and Black Titan (NASDAQ:BTTC) are both services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations.

Institutional & Insider Ownership

87.2% of Doximity shares are owned by institutional investors. 31.3% of Doximity shares are owned by insiders. Comparatively, 53.7% of Black Titan shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Doximity and Black Titan, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	1	7	12	2	2.68
Black Titan	1	0	0	0	1.00

Doximity currently has a consensus price target of $41.26, indicating a potential upside of 71.35%. Given Doximity’s stronger consensus rating and higher probable upside, research analysts clearly believe Doximity is more favorable than Black Titan.

Profitability

This table compares Doximity and Black Titan’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Doximity	37.54%	23.84%	20.42%
Black Titan	N/A	N/A	N/A

Volatility & Risk

Doximity has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Black Titan has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.

Earnings & Valuation

This table compares Doximity and Black Titan”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$570.40 million	7.80	$223.18 million	$1.20	20.07
Black Titan	$2.68 million	5.39	-$4.71 million	($2.95)	-0.49

Doximity has higher revenue and earnings than Black Titan. Black Titan is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Summary

Doximity beats Black Titan on 14 of the 15 factors compared between the two stocks.

About Doximity

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

About Black Titan

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.